What is Visioneering Technologies?
Founded in 2006 and based in Alpharetta, Georgia, Visioneering Technologies is a healthcare technology firm dedicated to pioneering advanced vision correction solutions. The company's core focus lies in developing cutting-edge optical technologies aimed at addressing prevalent eye conditions such as presbyopia in adults and myopia in children. Through inventive design methodologies, Visioneering Technologies strives to enhance the user experience for both eye care professionals and patients. With a robust portfolio of global patents covering on-eye and in-eye treatments, and having transitioned to a publicly traded entity in 2019, the company leverages its extensive expertise in clinical research, marketing, engineering, manufacturing, and regulatory affairs to introduce novel treatments for refractive errors including astigmatism.
How much funding has Visioneering Technologies raised?
Visioneering Technologies has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Visioneering Technologies?
The recent major strategic investment signifies a pivotal moment for Visioneering Technologies, likely enabling accelerated development and market penetration of its proprietary vision correction technologies. This capital infusion is expected to fuel further research and development, expand manufacturing capabilities, and bolster global commercialization efforts. As a publicly traded entity, Visioneering Technologies is positioned to capitalize on this strategic backing to solidify its market leadership in addressing unmet needs in eye care, particularly for conditions like presbyopia and myopia, thereby driving future growth and shareholder value.
See full Visioneering Technologies company page
